Selecting machine-learning scoring functions for structure-based virtual screening

Drug Discov Today Technol. 2019 Dec:32-33:81-87. doi: 10.1016/j.ddtec.2020.09.001. Epub 2020 Sep 19.

Abstract

Interest in docking technologies has grown parallel to the ever increasing number and diversity of 3D models for macromolecular therapeutic targets. Structure-Based Virtual Screening (SBVS) aims at leveraging these experimental structures to discover the necessary starting points for the drug discovery process. It is now established that Machine Learning (ML) can strongly enhance the predictive accuracy of scoring functions for SBVS by exploiting large datasets from targets, molecules and their associations. However, with greater choice, the question of which ML-based scoring function is the most suitable for prospective use on a given target has gained importance. Here we analyse two approaches to select an existing scoring function for the target along with a third approach consisting in generating a scoring function tailored to the target. These analyses required discussing the limitations of popular SBVS benchmarks, the alternatives to benchmark scoring functions for SBVS and how to generate them or use them using freely-available software.

Keywords: Artificial intelligence; Docking; Drug design; Machine learning; Virtual screening.

Publication types

  • Review

MeSH terms

  • Drug Discovery*
  • Humans
  • Machine Learning*
  • Pharmaceutical Preparations / chemistry*
  • Structure-Activity Relationship*

Substances

  • Pharmaceutical Preparations